Skip to Main Content

Paper Details

Systematic <i>In Vitro</i> Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia.
Front Oncol
3
2022
Author NameAffiliation
Michelle HaberChildren's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales (UNSW) Sydney
Michelle HaberUniversity of New South Wales (UNSW) Sydney
Michelle J HendersonChildren's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales (UNSW) Sydney
Michelle J HendersonUniversity of New South Wales (UNSW) Sydney
  • 1 - 4

Datasets

Release 1.2